Global Life Distribution Holdings Limited – Trademark Portfolio
Entity Type: 99
Global Life Distribution Holdings Limited holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 2 filings in this category. The portfolio also extends into Class 45 (Legal & Security Services) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include CHERISH. The owner is based in London.
30 St Mary Axe
London EC3A8EP , GB
Showing of trademarks Trademarks
Trademark Classifications
Global Life Distribution Holdings Limited's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Insurance; financial affairs; monetary affairs; real estate affairs
Legal services; security services for the protection of property and individuals
Frequently Asked Questions
How many trademarks does Global Life Distribution Holdings Limited have?
Global Life Distribution Holdings Limited has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Global Life Distribution Holdings Limited file in?
Global Life Distribution Holdings Limited files trademarks across 2 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 45 (Legal & Security Services). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.
What are Global Life Distribution Holdings Limited's most well-known trademarks?
Global Life Distribution Holdings Limited's registered trademark portfolio includes well-known marks such as CHERISH. These are among 2 currently registered trademarks in the portfolio.
What is Global Life Distribution Holdings Limited's trademark registration success rate?
Global Life Distribution Holdings Limited has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.